CN102336721B - Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid - Google Patents

Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid Download PDF

Info

Publication number
CN102336721B
CN102336721B CN201110204495.6A CN201110204495A CN102336721B CN 102336721 B CN102336721 B CN 102336721B CN 201110204495 A CN201110204495 A CN 201110204495A CN 102336721 B CN102336721 B CN 102336721B
Authority
CN
China
Prior art keywords
solvent
thiazolyl
amino
water
moisture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201110204495.6A
Other languages
Chinese (zh)
Other versions
CN102336721A (en
Inventor
周志茂
刘振强
屈一新
董永利
王际东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei best pharmaceutical technology group Limited by Share Ltd
Beijing University of Chemical Technology
Original Assignee
SHIJIAZHUANG HEJIA HEALTH-CARE PRODUCTS CO LTD
Beijing University of Chemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIJIAZHUANG HEJIA HEALTH-CARE PRODUCTS CO LTD, Beijing University of Chemical Technology filed Critical SHIJIAZHUANG HEJIA HEALTH-CARE PRODUCTS CO LTD
Priority to CN201110204495.6A priority Critical patent/CN102336721B/en
Publication of CN102336721A publication Critical patent/CN102336721A/en
Application granted granted Critical
Publication of CN102336721B publication Critical patent/CN102336721B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid. The method comprises the following steps of: performing azeotropic dehydration on water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid by using a solvent in a reaction container; and directly synthesizing the AE-active ester. The method has the advantages of reducing filtering and drying processes in the original production process, increasing the utilization rate of 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid, saving investment and lowering the production cost of the AE-active ester along with extremely high industrial popularization value.

Description

A kind of method of utilizing the synthetic 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester of moisture ainothiazoly loximate
Technical field
The present invention relates to a kind of method of utilizing the synthetic 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester of moisture ainothiazoly loximate, be applicable to the production process of antibiotic intermediates.
Background technology
2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, be called again 2-(2-amino-4-thiazolyl)-2-(methoxyimino) acetic acid sulfo-benzothiazole ester, English by name: 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic, thiobenzothiazole ester, referred to as MAEM, CAS is numbered 80765-85-0, molecular formula is: C13H10N3O2S3, molecular weight is: 350.44, and fusing point, at 128~130 ℃, is off-white color or faint yellow needle crystal powder.Ainothiazoly loximate, be called again 2-methoxy imino-2-(2-aminothiazole)-4-acetic acid, its English name is (Z)-2-(2 – aminothiazol-4-yl)-2-methoxyiminoacetic acid, referred to as ATMAA, CAS is numbered 65872-41-5, and molecular formula is C 6h 7n 3o 3s, molecular weight is 201.21.Anhydrous ainothiazoly loximate is white or off-white powder shape crystal, 182~184 ℃ of fusing points.Moisture ainothiazoly loximate is white or off-white color needle-like crystal, and molecular formula is C 6h 7n 3o 3s1.5H2O, 167~170 ℃ of fusing points.
The 4th generation the developing rapidly of cynnematin, also accelerated the development of the Intermediates Industry supporting with it.Be subject to stimulation and the promotion of cynnematin great market, the demand of domestic pharmaceutical intermediate is doubled and redoubled, output is developed rapidly.At present, China becomes topmost medicine intermediate producing country in the world gradually.Ainothiazoly loximate and 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, as the important intermediate of Cephalosporins, can synthesize multiple important cynnematins such as comprising ceftriaxone, cefpirome, cefotaxime.China is the major country of production of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, and annual production surpasses 2000 tons, still can not meet the needs of international and domestic market.
What the technique of production 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester generally adopted at present is to take methyl aceto acetate as starting raw material, through oximate, methylate, bromination, distillation, ring-closure reaction obtain Ethyl Methylaminothiazolyloximate, in alkaline aqueous solution, be hydrolyzed, by acid adjustment crystallization, obtain moisture ainothiazoly loximate.Through solvent dehydration is refining, obtain anhydrous ainothiazoly loximate, the condensation reaction under triphenylphosphine and triethylamine catalysis with anhydrous ainothiazoly loximate and dibenzothiazyl disulfide, then obtain 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester through purifying.Reaction principle is as follows:
The synthetic of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester must react in anhydrous solvent, so moisture ainothiazoly loximate must be refined and obtain anhydrous ainothiazoly loximate through solvent dehydration.In order to remove the crystal water in moisture ainothiazoly loximate, at present industrially generally moisture ainothiazoly loximate is dissolved in methyl alcohol or ethanolic soln, after high temperature reflux certain hour, filter, vacuum drying obtains anhydrous ainothiazoly loximate.While dewatering with alcoholic solvent, the moisture in raw material enters in solvent and causes the moisture in solution constantly to increase, so weaken to the water separation capability of later stage alcoholic solvent, dewatering time is extended.In addition, the alcoholic solvent compound that while dewatering with alcoholic solvent, the last product forming is ainothiazoly loximate must just can obtain anhydrous ainothiazoly loximate after alcoholic solvent is sloughed in vacuum-drying, for synthesizing of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.The shortcomings such as this production technique reactions steps is many, reaction time is long, manipulation strength is large, yield is low and the three wastes are many.
Summary of the invention
The invention provides a kind of and water has the solvent of azeotropic to deviate from the crystal water of ainothiazoly loximate and then the method for producing 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.The method does not need the process of vacuum-drying dealcoholysis kind solvent, thereby has greatly improved production efficiency.By solvent and water azeotropic, the moisture in solution is constantly taken out of, the crystal water of ainothiazoly loximate can be removed to very low level; This solvent is the solvent of synthetic 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester simultaneously, remove like this ainothiazoly loximate and this solvate of after crystal water, forming and just can directly carry out the synthetic of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, save filtration and baking operation while originally deviating from ainothiazoly loximate crystal water with alcohols, thereby can in a reactor, carry out the dehydration of ainothiazoly loximate and synthesizing of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
Feature of the present invention is:
1. the solvent of employing and water azeotropic, first dissolves moisture ainothiazoly loximate at a certain temperature, and the crystal water of ainothiazoly loximate is dissolved in solvent, then by solvent azeotropic dehydration, has accelerated the process of ainothiazoly loximate dehydration.
2. the ainothiazoly loximate solution of sloughing after crystal water can directly carry out the synthetic of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
3. by improving ainothiazoly loximate dewatering process, make to realize the dehydration of ainothiazoly loximate and synthesizing of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester in same reactor.Save filtration and baking operation after former technique ainothiazoly loximate dehydration, saved investment, improved the utilization ratio of ainothiazoly loximate, can reduce the production cost of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
Technical scheme
The invention provides a kind of method of utilizing the synthetic 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester of moisture ainothiazoly loximate, it is characterized in that comprising the following steps: moisture ainothiazoly loximate is dissolved in and can be formed in the solvent of azeotrope with water, then carry out azeotropic, thereby water is removed.In the method for the invention, from being dissolved in, moisture ainothiazoly loximate can form the solvent of azeotrope to finally obtaining not using alcoholic solvent in the whole process of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, as methyl alcohol or ethanol etc. with water.Thereby do not use alcoholic solvent to avoid hyperthermia drying to remove the step of alcoholic solvent, thereby greatly enhance productivity.One skilled in the art will appreciate that when having alcohols material to exist, can greatly affect the generation of 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
Described solvent is selected from the solvent system of acetonitrile, methylene dichloride, benzene,toluene,xylene, ethylene dichloride, trichloromethane, ethyl acetate, ether, tetracol phenixin, pyridine or its compositions of mixtures, or be selected from described solvent system and acetone, N, dinethylformamide, N, the mixed system that N-diethylformamide or N,N-dimethylacetamide form.
Described solvent is preferably anhydrous solvent, can make like this dewatering efficiency higher.
Method of the present invention also existed at the temperature of 35~90 ℃ and stirs so that the crystal water in ainothiazoly loximate is transferred to the step in solvent before carrying out azeotropic.More specifically, be at the temperature of 35~90 ℃, stir in reflux, return time is no more than 2 hours, preferably 0.5-2 hour.
Weight of solvent of the present invention is 1~5 times of moisture ainothiazoly loximate weight.
In method of the present invention, in azeotropic water removing process, if quantity of solvent is not enough, supplementing solvent more.
In method of the present invention, by azeotropic water removing, make moisture content in final solution preferably lower than 0.1wt%.
In method of the present invention, after azeotropic water removing, cool to 0~10 ℃, add dibenzothiazyl disulfide, triphenylphosphine, triethylamine to stir lower reaction 3 hours, filter and obtain 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
Concrete reaction process of the present invention is in a reactor, moisture ainothiazoly loximate is dissolved in the solvent of 1~5 times of moisture ainothiazoly loximate weight, and in temperature, be 35~90 ℃, stir solvent is transferred to the crystal water in ainothiazoly loximate in solvent.Solvent and water generates azeotropic, thus water is taken out of to reactor.By supplementing anhydrous solvent, the moisture content in final solution lower than 0.1% time, stops dehydration, cools to 0~10 ℃, adds dibenzothiazyl disulfide, triphenylphosphine, triethylamine to stir lower reaction 3 hours, filters and obtains 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
The present invention used solvent for there is the solvent of azeotropic with water, this solvent comprises the mixed system of two or more solvents of acetonitrile, methylene dichloride, benzene,toluene,xylene, ethylene dichloride, trichloromethane, ethyl acetate, ether, tetracol phenixin, pyridine equal solvent or above-mentioned solvent, or above-mentioned solvent and acetone, N, dinethylformamide, N, the mixed system of N-diethylformamide, N,N-dimethylacetamide.
The present invention's quantity of solvent used is preferably 1~5 times of moisture ainothiazoly loximate weight.
Moisture ainothiazoly loximate of the present invention is in solvent, and temperature is 35~90 ℃, reflux 0.5 ~ 2 hour.
The present invention will make solvent carry out azeotropic dehydration preferably to carry out 0.5 ~ 2 hour, and extraction water-containing solvent supplements anhydrous solvent.
The present invention will make the moisture content in final solution low to being enough to not affect ainothiazoly loximate and dibenzothiazyl disulfide carries out condensation reaction under triphenylphosphine and triethylamine catalysis, and its moisture content is that those skilled in the art are confirmable.Preferably, moisture content during lower than 0.1wt%, stops dehydration, cools to 0~10 ℃, adds dibenzothiazyl disulfide, triphenylphosphine, triethylamine to stir lower reaction 3 hours, filters and obtains 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.
The present invention preferably in having carried out the solution that azeotropic water removing obtains, directly add dibenzothiazyl disulfide, triphenylphosphine and triethylamine stir under reaction add again after making 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester or adding the anhydrous solvent of appropriate amount dibenzothiazyl disulfide, triphenylphosphine and triethylamine stir under reaction make 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.This process does not comprise the step that solvent is dried.
Embodiment
By example, the present invention is described below, but does not limit the present invention.
Embodiment 1: the moisture ainothiazoly loximate of getting 50g, put into 500mL crystallizer, 200g solvent acetonitrile, is heated to boiling reflux 0.5hr, then extraction water-containing solvent, supplement anhydrous acetonitrile, moisture in solution is reduced to while being less than 0.1%, is cooled to 5 ℃, adds acetonitrile to the 150mL 150mL that adds methylene chloride again, add dibenzothiazyl disulfide, triphenylphosphine, triethylamine to stir 3 hours, filter and obtain 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.Product yield 94.3%.
Embodiment 2: the moisture ainothiazoly loximate of getting 50g, put into 500mL crystallizer, 300g solvent acetone, is heated to boiling reflux 1hr, then extraction water-containing solvent, supplement methylene dichloride, when the moisture in solution reaches requirement, be cooled to 10 ℃, add acetone and methylene dichloride to 400mL, add dibenzothiazyl disulfide, triphenylphosphine, triethylamine to stir 3 hours, filter and obtain 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester.Product yield 93.5%.

Claims (5)

1. a method of utilizing the synthetic 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester of moisture ainothiazoly loximate, comprise the following steps: moisture ainothiazoly loximate is dissolved in and can be formed in the solvent of azeotrope with water, then carry out azeotropic, thereby water is removed, it is characterized in that described solvent is selected from acetonitrile, the solvent system that methylene dichloride forms, or be selected from the mixed system that described solvent system and acetone form, by azeotropic water removing, make moisture content in final solution lower than 0.1wt%, after azeotropic water removing, cool to 0~10 ℃, add dibenzothiazyl disulfide, triphenylphosphine and triethylamine stir lower reaction 3 hours, filtration obtains 2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic,thiobenzothiazole ester, the molecular formula of wherein said moisture ainothiazoly loximate is C 6h 7n 3o 3s1.5H 2o.
2. the method for claim 1, is characterized in that, also existed at the temperature of 35~90 ℃ and stirred so that the crystal water in ainothiazoly loximate is transferred to the step in solvent before carrying out azeotropic.
3. method as claimed in claim 2, is characterized in that, reflux when stirring at the temperature of 35~90 ℃, and return time is no more than 2 hours.
4. the method for claim 1, is characterized in that, weight of solvent is 1~5 times of moisture ainothiazoly loximate weight.
5. the method for claim 1, is characterized in that, in azeotropic water removing process, if quantity of solvent is not enough, and supplementing solvent more.
CN201110204495.6A 2011-07-21 2011-07-21 Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid Active CN102336721B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110204495.6A CN102336721B (en) 2011-07-21 2011-07-21 Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110204495.6A CN102336721B (en) 2011-07-21 2011-07-21 Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid

Publications (2)

Publication Number Publication Date
CN102336721A CN102336721A (en) 2012-02-01
CN102336721B true CN102336721B (en) 2014-09-17

Family

ID=45512718

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110204495.6A Active CN102336721B (en) 2011-07-21 2011-07-21 Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid

Country Status (1)

Country Link
CN (1) CN102336721B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104387337A (en) * 2014-12-15 2015-03-04 山东鑫泉医药有限公司 Method for synthesizing 3-ethyl-2-sulfur ethyl benzothiazole perchlorate by AE (Active Ester) residues
CN111024847B (en) * 2019-12-24 2022-03-01 河北合佳医药科技集团股份有限公司 Method for determining purity of AE-active ester by pre-column derivatization method
CN112480026B (en) * 2020-12-17 2023-04-07 山东金城医药化工有限公司 Method for producing AE-active esters

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
氨噻肟酸与AE-活性酯合成的研究进展;肖海焕等;《河南化工》;20081231;第25卷(第7期);第4-7页 *
肖海焕等.氨噻肟酸与AE-活性酯合成的研究进展.《河南化工》.2008,第25卷(第7期),第4-7页.

Also Published As

Publication number Publication date
CN102336721A (en) 2012-02-01

Similar Documents

Publication Publication Date Title
CN106256824B (en) Preparation method of high-purity delafloxacin meglumine salt
CN102336721B (en) Method for synthesizing AE-active ester by using water-containing 2-(2-amino-4-thiazolyl)-2-(Z)-methoxyimino acetic acid
CN107573330B (en) Preparation method of topiroxostat
CN105017168A (en) New preparation method of [5-bromo-4-(4-cyclopropyl-naphthalene-1-yl)-4H-[1, 2, 4]triazole-3-ylsulfanyl]-methyl acetate
CN103724288B (en) Triethyl orthoformate legal system is for the post-treating method of 1H-tetrazole-1-acetic acid
CN104529935B (en) Method for synthesizing ethyl 2-(3-aldehyde-4-isobutyloxyphenyl)-4-methylthiazole-5-formate
CN102391128B (en) Production method of antibiotic pharmaceutical intermediate mono-p-nitro benzyl malonate
CN101747291B (en) Method for synthesizing AE-active ester
CN101289464B (en) Process for recovering triphenyl phosphine oxide and 2-mercaptobenzothiazole from production waste liquid of cephalothin active ester
CN103788010A (en) Febuxostat intermediate and preparation method thereof
CN106883227B (en) The method for preparing ergometrine by ergot fermentation waste
CN103172530B (en) Preparation method of tolfenamic acid
CN104945357A (en) Refining method of dehydroandrographolide succinate
CN107892676A (en) The preparation method of Cefdinir active thioester
CN101870704A (en) Method for purifying cefotetan acid crude products
CN101508678A (en) Process for preparing 2-methyl-4-amino-5-acetyl aminomethyl pyrimidine
CN104478825A (en) Synthetic method of 2-(2-aminothiazole-4-yl)-2-methoxyiminoacetic acid
CN105646176B (en) The preparation method of 4,5 dibromo phthalic acids
CN108484526B (en) Method for synthesizing AE active ester by ester exchange method
CN102453041B (en) Environment-friendly impurity-removal manufacturing method
CN106083833B (en) Purification method of trityl olmesartan medoxomil
CN101712687B (en) Method for preparing intermediate of cefetamet pivoxil hydrochloride
CN101475541B (en) Preparation of 4-methyl thiazole-5-carboxyl acid
CN102964411B (en) Synthesis method of androstane-4,6-diene-17 alpha-methyl-17 beta-alcohol-3-ketone
CN103159751A (en) A preparation method for the derivates of phenylpyruvic acid amide ketals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 100029 Beijing, North Third Ring Road, No. 15 East Road, Chaoyang District

Patentee after: Beijing University of Chemical Technology

Patentee after: HEBEI HEJIA MEDICINE TECHNOLOGY GROUP CO., LTD.

Address before: 100029 Beijing, North Third Ring Road, No. 15 East Road, Chaoyang District

Patentee before: Beijing University of Chemical Technology

Patentee before: Shijiazhuang Hejia Health-Care Products Co.,Ltd.

C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 100029 Beijing, North Third Ring Road, No. 15 East Road, Chaoyang District

Patentee after: Beijing University of Chemical Technology

Patentee after: Hebei best pharmaceutical technology group Limited by Share Ltd

Address before: 100029 Beijing, North Third Ring Road, No. 15 East Road, Chaoyang District

Patentee before: Beijing University of Chemical Technology

Patentee before: HEBEI HEJIA MEDICINE TECHNOLOGY GROUP CO., LTD.